Home › Funds › Principal Global Investors › PCVX
Principal Global Investors position in PCVX
VAXCYTE INC · Health Care
Latest position (Q2 2026)7.71K sh
Reported value held$448.24K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 10.12K | $257.00K | New |
| Q2 2022 | 14.50K | $315.00K | New |
| Q3 2022 | 14.27K | $342.00K | Reduce |
| Q4 2022 | 18.46K | $885.25K | Add |
| Q1 2023 | 17.31K | $648.70K | Reduce |
| Q2 2023 | 22.16K | $1.11M | Add |
| Q3 2023 | 21.63K | $1.10M | Reduce |
| Q4 2023 | 22.01K | $1.38M | Add |
| Q1 2024 | 24.60K | $1.68M | Add |
| Q2 2024 | 18.41K | $1.39M | Reduce |
| Q3 2024 | 52.70K | $6.02M | Add |
| Q4 2024 | 308.94K | $25.29M | Add |
| Q1 2025 | 469.56K | $17.73M | Add |
| Q2 2025 | 8.61K | $279.98K | Reduce |
| Q3 2025 | 7.99K | $287.94K | Reduce |
| Q4 2025 | 4.93K | $227.56K | Reduce |
| Q1 2026 | 5.28K | $306.53K | Add |
| Q2 2026 | 7.71K | $448.24K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCVX
- Fidelity Management & Research (FMR) 20.85M sh · $1.21B · Q2 2026
- Janus Henderson Group 16.58M sh · $960.23M · Q1 2026
- BlackRock Inc 12.07M sh · $701.52M · Q2 2026
- Vanguard Group 12.19M sh · $562.63M · Q4 2025
- Wellington Management Group 7.00M sh · $407.00M · Q2 2026
- Geode Capital Management 3.46M sh · $201.13M · Q2 2026
- D. E. Shaw & Co 1.90M sh · $110.56M · Q2 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- Charles Schwab Investment Management 1.46M sh · $85.15M · Q2 2026
- Goldman Sachs Group 1.38M sh · $79.98M · Q2 2026
- Northern Trust Corp 1.28M sh · $74.42M · Q2 2026
- Norges Bank Investment Management 1.25M sh · $72.42M · Q2 2026